Cardiovascular Morbidity in Patients Undergoing Successful Surgery for Primary Hyperparathyroidism
Clinical Endocrinology · 2025-11 · 103 (5) · 669-681
DOI: 10.1111/cen.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 12.08.2025. Verfasst von Martin Nilsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Skåne University Hospital Lund, Lund, Sweden. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Parathyroidectomy, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was funded from Thelma Zoégas Fond för Medicinsk forskning, Thorsten Birger Segerfalks Stiftelse, Carl J Michaelsens Donationsfond, Anna-Lisa och Sv….
Abstract (Originalsprache)
Objective
Although previous studies have shown reduced cardiovascular events following parathyroidectomy (PTX), it is unclear whether this extends to contemporary patients diagnosed and treated with milder disease than previously. The aim of this nation‐wide study was to determine the effect on cardiovascular events after PTX, and to comprehensively evaluate cardiovascular disease manifestations in patients with primary hyperparathyroidism, (pHPT).
Design
The cohort consisted of 5009 patients who underwent PTX and were identified from the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery. Patients were matched with 14,983 population controls.
Methods
Data was linked with the National Patient and Death Registries. Incidence rate ratios (IRRs) were estimated before and after PTX for recurrent events of acute myocardial infarction, stroke, transient ischemic attack (TIA), and first‐onset diagnoses of coronary artery disease, heart failure, aortic and mitral valve stenosis, carotid artery stenosis, peripheral artery disease, and aortic aneurysm (AA). Serum calcium and gland weight were analysed as predictors.
Results
TIA was increased in patients pre‐and postoperatively with a peak 1–4 years before PTX (IRR: 2.06, CI 95%: 1.31–3.25). The incidence rates for acute myocardial infarction and stroke were not increased pre‐ and postoperatively. Mitral valve stenosis (IRR: 3.22, 1.51–6.85), and heart failure (IRR: 1.37, 1.11–1.67) were increased preoperatively, but not postoperatively. AA was increased pre‐ and postoperatively.
Conclusions
The incidence rates for mitral valve stenosis and heart failure were increased preoperatively in patients with pHPT, normalizing after surgery. In contrast, the incidence of TIA and AA remained elevated postoperatively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Skåne University Hospital Lund, Lund, Sweden.
- Department of Clinical Sciences, Lund University, Lund, Sweden.
- The Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine and Science for Life Laboratory, Gothenburg University, Gothenburg, Sweden.
- Department of Cardiology, Skåne University Hospital, Lund, Sweden.
ORCID-Profile: Martin Nilsson
Förderung
- This study was funded from Thelma Zoégas Fond för Medicinsk forskning, Thorsten Birger Segerfalks Stiftelse, Carl J Michaelsens Donationsfond, Anna-Lisa och Sv…
Zitieren
APA
Nilsson, M., Smith, J. G., Thier, M., Nordenström, E., Bergenfelz, A., & Almquist, M. (2025). Cardiovascular Morbidity in Patients Undergoing Successful Surgery for Primary Hyperparathyroidism. Clinical Endocrinology, 103(5), 669-681. https://doi.org/10.1111/cen.70015
Vancouver
Nilsson M, Smith JG, Thier M, Nordenström E, Bergenfelz A, Almquist M. Cardiovascular Morbidity in Patients Undergoing Successful Surgery for Primary Hyperparathyroidism. Clinical Endocrinology. 2025;103(5):669-681. doi:10.1111/cen.70015
BibTeX
@article{Nilsson2025,
author = {Nilsson, Martin and Smith, J Gustav and Thier, Mark and Nordenström, Erik and Bergenfelz, Anders and Almquist, Martin},
title = {Cardiovascular Morbidity in Patients Undergoing Successful Surgery for Primary Hyperparathyroidism},
journal = {Clinical Endocrinology},
year = {2025},
volume = {103},
number = {5},
pages = {669--681},
doi = {10.1111/cen.70015}
}
EUVIMED